Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografske podrobnosti
Glavni avtor:	Salsabil, Labiba
Drugi avtorji:	Chowdhury, Namara Mariam
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2024
Teme:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Online dostop:	http://hdl.handle.net/10361/23932

Podobne knjige/članki

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Izdano: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Izdano: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Izdano: (2024)

Targeting circular RNA for cardiovascular diseases
od: Sarkar, Deepannita
Izdano: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Izdano: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
od: Islam, Md. Raihanul
Izdano: (2024)

Implications of unusual non-coding RNAs in human diseases
od: Ahmed, Tazkia
Izdano: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
od: Mostofa, Golam
Izdano: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Izdano: (2022)

A review on optogenetics and its potential in neurological disorder management
od: Armin, Fariza
Izdano: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
od: Suraiya, Tasnia Iffat
Izdano: (2023)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Izdano: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
od: Ferdous, Labiba
Izdano: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Izdano: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
od: Annee, Israt Jahan
Izdano: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Izdano: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
od: Nawar, Numia
Izdano: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
od: Afsana, Nourin
Izdano: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Izdano: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
od: Ahmad, Rafid Uddin, et al.
Izdano: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
od: Mithila, Sabekun Nahar
Izdano: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Izdano: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
od: Mahaleka, Aarshi
Izdano: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Izdano: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
od: Islam, Md. Rakibul
Izdano: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Izdano: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
od: Key, Nasrin Sultana
Izdano: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
od: Rawshan, A. E. Maisha
Izdano: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Izdano: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Izdano: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
od: Chowdhury, Amal
Izdano: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
od: Afreen, Nuraia
Izdano: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Izdano: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
od: Naureen, Ishrat
Izdano: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
od: Abedin, Khondokar Mezbahul
Izdano: (2023)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Izdano: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Izdano: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
od: Nuha, Nabiha Tahsin
Izdano: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
od: Asaduzzaman, et al.
Izdano: (2021)